Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TNFAIP2 was identified as a gene whose expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. Additionally we are shipping TNFAIP2 Kits (15) and TNFAIP2 Proteins (3) and many more products for this protein.
Showing 10 out of 43 products:
Knockdown of TNFaip2 in Raw264.7 cells inhibited formation of tunneling nanotubes.
A polarized secretion assay suggested that the silencing of endothelial myeloid-secretory impairs T effector transendothelial migration by reducing the preferential secretion of endothelial-produced CCL2 (show CCL2 Antibodies).
Data indicate that TNFAIP2 overexpression may facilitate proliferation and metastasis via activation of the Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling pathway in esophageal squamous cell carcinoma.
Taken together, genome-wide chromatin analysis of Legionella pneumophila-infected macrophages demonstrated induction of TNFAIP2, a NF-kappaB (show NFKB1 Antibodies)-dependent factor relevant for bacterial replication.
data suggest that TNFAIP2 is a novel inhibitor of NF-kappa-B (show NFKB1 Antibodies) that acts as an autoinhibitor of the TNFalpha (show TNF Antibodies) response during septic shock.
findings collectively suggest that TNFAIP2 is a direct KLF5 (show KLF5 Antibodies) target gene, and both KLF5 (show KLF5 Antibodies) and TNFAIP2 promote breast cancer cell proliferation, migration and invasion through Rac1 and Cdc42 (show CDC42 Antibodies)
A functional TNFAIP2 3'-UTR (show UTS2R Antibodies) rs8126 genetic polymorphism contributes to risk of esophageal squamous cell carcinoma.
the regulation of TNFAIP2 and its role in promoting NPC (show NPC1 Antibodies) tumor progression
The TNFAIP2 miRNA binding site rs8126 T>C single nucleotide polymorphism may be a marker for susceptibility to gastric cancer.
A functional variant at the miR (show MLXIP Antibodies)-184 binding site in TNFAIP2 is associated with squamous cell carcinoma of the head and neck.
TNFAIP2 may serve as a useful new marker of dendritic and histiocytic sarcomas.
This gene was identified as a gene whose expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. The expression of this gene was shown to be induced by retinoic acid in a cell line expressing a oncogenic version of the retinoic acid receptor alpha fusion protein, which suggested that this gene may be a retinoic acid target gene in acute promyelocytic leukemia.
TNF alpha-induced protein 2
, primary response gene B94 protein
, tumor necrosis factor alpha-induced protein 2
, tumor necrosis factor induced protein 2
, exocyst complex component 3-like 3